Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 19

1.

Recent milestones in achondroplasia research.

Horton WA.

Am J Med Genet A. 2006 Jan 15;140(2):166-9. No abstract available.

PMID:
16353253
2.

FGFR3 targeting strategies for achondroplasia.

Laederich MB, Horton WA.

Expert Rev Mol Med. 2012 Jan 19;14:e11. doi: 10.1017/erm.2012.4. Review.

PMID:
22559284
3.

Achondroplasia: from genotype to phenotype.

Richette P, Bardin T, Stheneur C.

Joint Bone Spine. 2008 Mar;75(2):125-30. Epub 2007 Sep 25. Review.

PMID:
17950653
4.

Advances in understanding etiology of achondroplasia and review of management.

Carter EM, Davis JG, Raggio CL.

Curr Opin Pediatr. 2007 Feb;19(1):32-7. Review.

PMID:
17224659
5.

[Cytokines in bone diseases. FGF receptor signaling and achondroplasia/hypochondroplasia].

Tanaka H.

Clin Calcium. 2010 Oct;20(10):1490-6. doi: CliCa101014901496. Review. Japanese.

PMID:
20890030
6.

[Genetic basis for skeletal disease. Genetic defects in chondrodysplasia].

Matsui Y.

Clin Calcium. 2010 Aug;20(8):1182-9. doi: CliCa100811821189. Review. Japanese.

PMID:
20675928
7.

Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia--genetic short limbed dwarfism.

Aviezer D, Golembo M, Yayon A.

Curr Drug Targets. 2003 Jul;4(5):353-65. Review.

PMID:
12816345
8.

Achondroplasia: pathogenesis and implications for future treatment.

Laederich MB, Horton WA.

Curr Opin Pediatr. 2010 Aug;22(4):516-23. doi: 10.1097/MOP.0b013e32833b7a69. Review.

PMID:
20601886
9.

Co-occurrence of achondroplasia and Down syndrome: Genotype/phenotype association.

de Azevedo Moreira LM, Matos MA, Schiper PP, Carvalho AF, Gomes IC, Rolemberg JC, Ferreira de Lima RL, Toralles MB.

Birth Defects Res A Clin Mol Teratol. 2010 Apr;88(4):228-31. doi: 10.1002/bdra.20653. Review.

PMID:
20222028
10.

[Updated treatment of achondroplasia].

Seino Y.

Clin Calcium. 2009 Mar;19(3):432-6. doi: CliCa0903432436. Review. Japanese.

PMID:
19252254
11.

[Association of achondroplasia to a mutation in the transmembrane domain of fibroblastic growth factor receptor 3 (FGFR3)].

Rousseau F, Bonaventure J, Le Merrer M, Munnich A.

Ann Endocrinol (Paris). 1996;57(3):151-2. Review. French. No abstract available.

PMID:
8949407
12.

Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism.

Horton WA, Lunstrum GP.

Rev Endocr Metab Disord. 2002 Dec;3(4):381-5. Review. No abstract available.

PMID:
12424440
13.

Some chondrodysplasias with short limbs: molecular perspectives.

Cohen MM Jr.

Am J Med Genet. 2002 Oct 15;112(3):304-13. Review.

PMID:
12357475
14.

[From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor].

van Ravenswaaij-Arts CM, Losekoot M.

Ned Tijdschr Geneeskd. 2001 Jun 2;145(22):1056-9. Review. Dutch.

PMID:
11414167
15.

Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia.

Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, Le Merrer M, Munnich A.

Horm Res. 1996;45(1-2):108-10. Review.

PMID:
8742128
16.

[Fibroblast growth factor receptor and achondroplasia].

Tanaka H.

Clin Calcium. 2006 Nov;16(11):1888-93. Review. Japanese.

PMID:
17079857
18.

Fibroblast growth factor receptor 3 and the human chondrodysplasias.

Horton WA.

Curr Opin Pediatr. 1997 Aug;9(4):437-42. Review.

PMID:
9300204
19.

A new biological framework for cancer research.

Schipper H, Turley EA, Baum M.

Lancet. 1996 Oct 26;348(9035):1149-51. Review. No abstract available.

PMID:
8888171
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk